What's in OSI Pharmaceuticals's pipeline?

OSI Pharmaceuticals has 3 drugs in our index: 0 marketed, 0 filed, 1 in Phase 3, 1 in Phase 2, 1 in Phase 1.

Which companies overlap with OSI Pharmaceuticals's portfolio?

Top competitors by shared drug class: AstraZeneca, Karolinska University Hospital, Shanghai Henlius Biotech, Swiss Cancer Institute, The University of Hong Kong.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/osi-pharmaceuticals.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-16 · How we verify

OSI Pharmaceuticals — Portfolio Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

OSI Pharmaceuticals pipeline: 0 marketed, 0 filed, 1 Phase 3, 1 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

0 marketed 0 filed 1 Phase 3 1 Phase 2 1 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area	First approval
Combination carboplatin and paclitaxel	Combination carboplatin and paclitaxel	phase 3	Chemotherapy combination (platinum agent + taxane)	DNA (carboplatin); β-tubulin (paclitaxel)	Oncology

Therapeutic area mix

Oncology · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

AstraZeneca · 1 shared drug class
Karolinska University Hospital · 1 shared drug class
Shanghai Henlius Biotech · 1 shared drug class
Swiss Cancer Institute · 1 shared drug class
The University of Hong Kong · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for OSI Pharmaceuticals:

Cite this brief

Drug Landscape (2026). OSI Pharmaceuticals — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/osi-pharmaceuticals. Accessed 2026-05-16.